| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702111 | Journal of Thoracic Oncology | 2016 | 21 Pages |
Abstract
In patients with completely resected T2N0M0, adjuvant chemotherapy is associated with improved survival in all tumor size groups. The benefit in patients with tumors smaller than 4 cm strongly suggests a role for chemotherapy in this patient population and counters its current status as an exclusion criteria for adjuvant trials.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel MD, Lingling MD, Saiama N. MD, Aalok MD, Pamela MD, Siddhartha MD, Feng PhD, Cliff G. MD, Jeffrey MD, Maria MD, Ashiq MD, Ramaswamy MD, Varun MD, MSCI,